Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab.
Bernd SchultesBarbara ErnstSebastian M SchmidPublished in: Acta diabetologica (2021)